Diagnostic Challenges and Treatment of Concurrent Toxoplasmosis and Disseminated Cryptococcus in an Immunocompromised Patient

<b>Background:</b> Co-infection with disseminated cryptococcosis and toxoplasma encephalitis is rare but presents significant diagnostic and therapeutic challenges, particularly in severely immunocompromised patients. This case study highlights the complexities involved in managing such dual infections. <b>Case Presentation:</b> We describe a 43-year-old Hispanic male with Stage IV EBV-positive diffuse large B-cell lymphoma and hemophagocytic lymphohistiocytosis who presented with progressive weakness and altered mental status. Initial brain MRI revealed multiple enhancing lesions. Diagnostic tests for cryptococcosis and toxoplasma were inconclusive; however, a positive cryptococcal antigen test, new lung nodules, and potential central nervous system involvement suggested possible disseminated cryptococcosis. Diagnosis of cryptococcal meningoencephalitis could not be confirmed due to negative CSF cultures. <b>Management and Outcome:</b> Despite initiating treatment with amphotericin B and flucytosine for suspected cryptococcosis, the patient's condition did not improve. Initial Karius and CSF PCR tests for Toxoplasma were negative. A subsequent brain biopsy, however, confirmed toxoplasmic encephalitis. Treatment was adjusted to intravenous Trimethoprim/Sulfamethoxazole for toxoplasmosis, with continued fluconazole for cryptococcosis. The patient exhibited significant clinical improvement with this revised therapy. <b>Conclusion:</b> Diagnosing concurrent cryptococcal and toxoplasma infections is challenging due to overlapping clinical symptoms and variability in test sensitivities. This case underscores the need for a comprehensive diagnostic approach and the critical role of brain biopsy when other diagnostic methods, such as Karius testing and CSF PCR, are inconclusive. Prompt empirical treatment based on clinical suspicion, with subsequent treatment adjustments guided by clinical response and follow-up assessments, is essential for effective management.

Authors

Institutions

Publication Details

Journal
Case Reports in Infectious Diseases
Published
2025-01-01
DOI
https://doi.org/10.1155/crdi/9917703
Primary Topic
Toxoplasma gondii Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Diagnostic Challenges and Treatment of Concurrent Toxoplasmosis and Disseminated Cryptococcus in an Immunocompromised Patient

Ann-Katrin Valencia, Davide Lecca, Brian Nudelman, Nicole Nudelman et al.
Case Reports in Infectious Diseases
Toxoplasma gondii Research Studies
article

Diagnostic Challenges and Treatment of Concurrent Toxoplasmosis and Disseminated Cryptococcus in an Immunocompromised Patient

Ann-Katrin Valencia, Davide Lecca, Brian Nudelman, Nicole Nudelman, Jhonathan Uribe
article en

Abstract

<b>Background:</b> Co-infection with disseminated cryptococcosis and toxoplasma encephalitis is rare but presents significant diagnostic and therapeutic challenges, particularly in severely immunocompromised patients. This case study highlights the complexities involved in managing such dual infections. <b>Case Presentation:</b> We describe a 43-year-old Hispanic male with Stage IV EBV-positive diffuse large B-cell lymphoma and hemophagocytic lymphohistiocytosis who presented with progressive weakness and altered mental status. Initial brain MRI revealed multiple enhancing lesions. Diagnostic tests for cryptococcosis and toxoplasma were inconclusive; however, a positive cryptococcal antigen test, new lung nodules, and potential central nervous system involvement suggested possible disseminated cryptococcosis. Diagnosis of cryptococcal meningoencephalitis could not be confirmed due to negative CSF cultures. <b>Management and Outcome:</b> Despite initiating treatment with amphotericin B and flucytosine for suspected cryptococcosis, the patient's condition did not improve. Initial Karius and CSF PCR tests for Toxoplasma were negative. A subsequent brain biopsy, however, confirmed toxoplasmic encephalitis. Treatment was adjusted to intravenous Trimethoprim/Sulfamethoxazole for toxoplasmosis, with continued fluconazole for cryptococcosis. The patient exhibited significant clinical improvement with this revised therapy. <b>Conclusion:</b> Diagnosing concurrent cryptococcal and toxoplasma infections is challenging due to overlapping clinical symptoms and variability in test sensitivities. This case underscores the need for a comprehensive diagnostic approach and the critical role of brain biopsy when other diagnostic methods, such as Karius testing and CSF PCR, are inconclusive. Prompt empirical treatment based on clinical suspicion, with subsequent treatment adjustments guided by clinical response and follow-up assessments, is essential for effective management.

Case Reports in Infectious DiseasesVol. 2025(1)
Memorial Healthcare System (US)
Good health and well-being
Openalex Percentile: Top 85%
Toxoplasma gondii Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.